News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
300,696 Results
Type
Article (15283)
Company Profile (34)
Press Release (285375)
Multimedia
Podcasts (27)
Webinars (5)
Section
Business (80720)
Career Advice (1342)
Deals (16015)
Drug Delivery (36)
Drug Development (48549)
Employer Resources (54)
FDA (7797)
Job Trends (6517)
News (151608)
Policy (12648)
Tag
Academia (1009)
Accelerated approval (8)
Adcomms (12)
Allergies (77)
Alliances (15328)
ALS (76)
Alzheimer's disease (797)
Antibody-drug conjugate (ADC) (132)
Approvals (7930)
Artificial intelligence (198)
Autoimmune disease (29)
Automation (12)
Bankruptcy (118)
Best Places to Work (5667)
BIOSECURE Act (4)
Biosimilars (82)
Biotechnology (25)
Bladder cancer (98)
Brain cancer (32)
Breast cancer (347)
Cancer (2499)
Cardiovascular disease (194)
Career advice (1044)
Career pathing (11)
CAR-T (115)
CDC (11)
Cell therapy (313)
Cervical cancer (22)
Clinical research (43229)
Collaboration (721)
Company closure (2)
Compensation (564)
Complete response letters (22)
COVID-19 (1258)
CRISPR (39)
C-suite (221)
Cystic fibrosis (57)
Data (2871)
Denatured (1)
Depression (49)
Diabetes (269)
Diagnostics (2780)
Digital health (18)
Diversity (1)
Diversity, equity & inclusion (11)
Drug discovery (88)
Drug pricing (38)
Drug shortages (10)
Duchenne muscular dystrophy (113)
Earnings (52179)
Editorial (17)
Employer branding (8)
Employer resources (47)
Events (48976)
Executive appointments (497)
FDA (9350)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (3)
Frontotemporal dementia (7)
Funding (632)
Gene editing (83)
Generative AI (9)
Gene therapy (261)
GLP-1 (522)
Government (1699)
Grass and pollen (5)
Guidances (316)
Healthcare (8187)
HIV (33)
Huntington's disease (21)
IgA nephropathy (36)
Immunology and inflammation (111)
Immuno-oncology (10)
Indications (35)
Infectious disease (1376)
Inflammatory bowel disease (94)
Inflation Reduction Act (6)
Influenza (51)
Intellectual property (87)
Interviews (251)
IPO (9721)
IRA (14)
Job creations (1190)
Job search strategy (911)
Kidney cancer (12)
Labor market (34)
Layoffs (236)
Leadership (14)
Legal (2053)
Liver cancer (59)
Longevity (5)
Lung cancer (370)
Lymphoma (207)
Machine learning (12)
Management (17)
Manufacturing (242)
MASH (89)
Medical device (5995)
Medtech (6003)
Mergers & acquisitions (6865)
Metabolic disorders (623)
Multiple sclerosis (84)
NASH (17)
Neurodegenerative disease (94)
Neuropsychiatric disorders (23)
Neuroscience (1331)
NextGen: Class of 2025 (2419)
Non-profit (2098)
Now hiring (10)
Obesity (276)
Opinion (102)
Ovarian cancer (81)
Pain (90)
Pancreatic cancer (110)
Parkinson's disease (133)
Partnered (5)
Patents (185)
Patient recruitment (166)
Peanut (38)
People (13807)
Pharmaceutical (13)
Pharmacy benefit managers (7)
Phase I (10792)
Phase II (17765)
Phase III (18340)
Pipeline (2030)
Policy (69)
Postmarket research (1374)
Preclinical (3680)
Press Release (18)
Prostate cancer (130)
Psychedelics (17)
Radiopharmaceuticals (131)
Rare diseases (319)
Real estate (1549)
Recruiting (21)
Regulatory (10659)
Reports (31)
Research institute (932)
Resumes & cover letters (256)
Rett syndrome (9)
RNA editing (5)
RSV (40)
Schizophrenia (88)
Series A (90)
Series B (73)
Service/supplier (5)
Sickle cell disease (44)
Special edition (19)
Spinal muscular atrophy (106)
Sponsored (19)
Startups (1091)
Stomach cancer (6)
Supply chain (52)
Tariffs (29)
The Weekly (26)
Vaccines (458)
Venture capital (34)
Weight loss (158)
Women's health (25)
Worklife (10)
Date
Today (92)
Last 7 days (271)
Last 30 days (1471)
Last 365 days (21803)
2025 (15176)
2024 (20537)
2023 (21229)
2022 (25568)
2021 (26883)
2020 (25280)
2019 (20186)
2018 (15167)
2017 (15632)
2016 (13557)
2015 (16116)
2014 (11829)
2013 (8845)
2012 (9257)
2011 (9743)
2010 (8375)
Location
Africa (378)
Alabama (27)
Alaska (3)
Arizona (55)
Arkansas (8)
Asia (21134)
Australia (3941)
California (5927)
Canada (1560)
China (545)
Colorado (237)
Connecticut (265)
Delaware (179)
Europe (43772)
Florida (730)
Georgia (178)
Hawaii (2)
Idaho (19)
Illinois (435)
India (23)
Indiana (232)
Iowa (10)
Japan (230)
Kansas (60)
Kentucky (11)
Louisiana (10)
Maine (39)
Maryland (617)
Massachusetts (4181)
Michigan (102)
Minnesota (306)
Mississippi (4)
Missouri (61)
Montana (12)
Nebraska (6)
Nevada (70)
New Hampshire (39)
New Jersey (1635)
New Mexico (8)
New York (1506)
North Carolina (727)
North Dakota (4)
Northern California (2738)
Ohio (151)
Oklahoma (5)
Oregon (15)
Pennsylvania (1114)
Puerto Rico (9)
Rhode Island (17)
South America (545)
South Carolina (20)
Southern California (2284)
Tennessee (75)
Texas (869)
United States (20184)
Utah (134)
Virginia (144)
Washington D.C. (37)
Washington State (490)
West Virginia (2)
Wisconsin (66)
300,696 Results for "3".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
Bayer Makes Potential $1.3B Cancer Bet in Kumquat Deal
For $1.3 billion in aggregate—including upfront and milestone payments—Bayer will get exclusive global access to Kumquat Biosciences’ small-molecule KRAS G12D blocker.
August 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Onco3R Therapeutics Announces Approval of First Clinical Trial Application for Novel SIK3 inhibitor O3R-5671 in Autoimmune Diseases
September 4, 2025
·
3 min read
Press Releases
Arrowhead Pharmaceuticals Completes Enrollment in SHASTA-3, SHASTA-4, and MUIR-3 Phase 3 Studies of Plozasiran
June 23, 2025
·
8 min read
Press Releases
Biodexa Moves Into Phase 3 With eRapa For FAP With First Patients Enrolled
September 8, 2025
·
6 min read
Press Releases
Artelo Biosciences Announces Closing of $3.0 Million Public Offering
September 8, 2025
·
4 min read
Press Releases
Microbix Reports Results for Q3 Fiscal 2025
August 15, 2025
·
8 min read
Press Releases
TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced Enrollment
September 8, 2025
·
16 min read
Press Releases
Spectral Medical Receives US$3 Million From Vantive
August 25, 2025
·
3 min read
Press Releases
Artelo Biosciences Announces Pricing of $3.0 Million Public Offering
September 5, 2025
·
4 min read
Press Releases
Coherus Oncology to Participate in Upcoming Investor Conferences - September 3, 2025
September 4, 2025
·
2 min read
1 of 30,070
Next
